James E Newsome Net Worth

The estimated Net Worth of James E Newsome is at least $1.37 Milione dollars as of 14 June 2010. James Newsome owns over 1,200 units of CME Inc stock worth over $392,588 and over the last 16 years James sold CME stock worth over $974,922.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

James Newsome CME stock SEC Form 4 insiders trading

James has made over 2 trades of the CME Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently James sold 1,200 units of CME stock worth $372,540 on 14 June 2010.

The largest trade James's ever made was selling 2,200 units of CME Inc stock on 27 August 2009 worth over $602,382. On average, James trades about 567 units every 49 days since 2008. As of 14 June 2010 James still owns at least 1,796 units of CME Inc stock.

You can see the complete history of James Newsome stock trades at the bottom of the page.

Insiders trading at CME Inc

Over the last 21 years, insiders at CME Inc have traded over $264,111,034 worth of CME Inc stock and bought 77,667 units worth $15,169,350 . The most active insiders traders include Terrence A Duffy, Phupinder Gill e Bryan T Durkin. On average, CME Inc executives and independent directors trade stock every 10 days with the average trade being worth of $863,868. The most recent stock trade was executed by Bryan T Durkin on 30 August 2024, trading 7,593 units of CME stock currently worth $1,629,382.

What does CME Inc do?

as the world's leading and most diverse derivatives marketplace, cme group (www.cmegroup.com) is where the world comes to manage risk. cme group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. cme group brings buyers and sellers together through its cme globex® electronic trading platform and its trading facilities in new york and chicago. cme group also operates cme clearing, one of the world’s leading central counterparty clearing provider in the world, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through cme clearport®. these products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.

Complete history of James Newsome stock trades at CME Inc

CME Inc executives and stock owners

CME Inc executives and other stock owners filed with the SEC include:

• Terrence Duffy,
  Executive Chairman of the Board, Chief Executive Officer
• Michael Spencer,
  Director
• Terrence A. Duffy,
  Chairman & CEO
• John Pietrowhicz,
  Chief Financial Officer
• Sean Tully,
  Senior Managing Director - Financial and OTC Products
• Julie Holzrichter,
  Chief Operating Officer, Senior Managing Director
• Kevin Kometer,
  Chief Information Officer, Senior Managing Director
• John William Pietrowicz M.B.A., CPA,
  Chief Financial Officer
• Kevin D. Kometer,
  Sr. MD & Chief Information Officer
• Julie Holzrichter,
  Sr. MD & COO
• Sunil Cutinho,
  Pres of CME Clearing
• Dennis Suskind,
  Independent Director
• Daniel Glickman,
  Lead Independent Director
• Larry Gerdes,
  Independent Director
• Dennis Chookaszian,
  Independent Director
• Timothy Bitsberger,
  Independent Director
• Howard Siegel,
  Independent Director
• Martin Gepsman,
  Independent Director
• William Shepard,
  Independent Director
• Elizabeth Cook,
  Independent Director
• Terry Savage,
  Independent Director
• Charles Carey,
  Vice Chairman of the Board
• Ronald Pankau,
  Independent Director
• Deborah Lucas,
  Independent Director
• William Hobert,
  Independent Director
• Ana Dutra,
  Independent Director
• Gedon Hertshten,
  Independent Director
• Daniel Kaye,
  Independent Director
• Phyllis Lockett,
  Independent Director
• Yra Harris,
  Independent Director
• Patrick Maloney,
  Independent Director
• Julie Winkler,
  Senior Managing Director, Chief Commercial Officer
• Kendal Vroman,
  Senior Managing Director - International and Optimization Services
• Derek Sammann,
  Senior Managing Director - Commodity and Options
• Kathleen Cronin,
  Senior Managing Director, General Counsel, Corporate Secretary
• Jack Tobin,
  Chief Accounting Officer
• Hilda Piell,
  Chief Human Resource Officer, Senior Managing Director
• Sunil Cutinho,
  President - CME Clearing
• Hilda Harris Piell,
  Sr. MD & Chief HR Officer
• Anita Liskey,
  Sr. Managing Director of Corp. Marketing & Communications
• Kathleen M. Cronin,
  Sr. MD, Gen. Counsel & Corp. Sec.
• John C. Peschier,
  Managing Director of Investor Relations
• Jack Tobin,
  MD & Chief Accounting Officer
• Kimberly S Taylor,
  MD & Pres., Clearing House
• John W. Pietrowicz,
  Sr MD Chief Financial Officer
• Robert Zagotta,
  Director
• Phupinder Gill,
  Managing Director, Clearing
• Jeffrey M. Bernacchi,
  Director
• Leo Melamed,
  Director
• John F Sandner,
  Director
• Alex J Pollock,
  Director
• David J Wescott,
  Director
• James E. Parisi,
  MD & CFO
• Steven E Wollack,
  Director
• William P Ii Miller,
  Director
• James E Oliff,
  Director
• Jill A Harley,
  MD & CAO
• J. Dennis Hastert,
  Director
• Bruce F Johnson,
  Director
• James A Donaldson,
  Director
• C C Ii Odom,
  Director
• Linda Dallas Rich,
  Sr MD Govt Rel Legisl Affairs
• Laurent Paulhac,
  MD OTC Products
• James V. Pieper,
  MD & CAO
• Christopher Stewart,
  Director
• Jackie M Clegg,
  Director
• Scot E. Warren,
  MD Equity Index Prod & Svcs
• Gary M Katler,
  Director
• Mark E Cermak,
  Director
• Joseph Niciforo,
  Director
• Mazen Chadid,
  MD Operations
• James R Krause,
  Man. Director, Operations
• Eileen Keeve,
  Managing Director
• Myron S Scholes,
  Director
• Richard H Redding,
  MD, Products & Services
• Barry C Goldblatt,
  MD Comm Energy & Metal Prods
• Patrick B Lynch,
  Director
• Nancy W Goble,
  Man. Dir & Chief Acc. Off
• Elizabeth Harrington,
  Director
• John Roth Iii Roberts,
  MD & CMO
• Scott Gordon,
  Director
• Robert J Jr Tierney,
  Director
• Robert H Steele,
  Director
• Satish Nandapurkar,
  Managing Director
• Scott L Johnston,
  Man. Dir. & Chief Inf. Off.
• Craig S Donohue,
  EVP & CAO, Office of the CEO
• William G Jr Salatich,
  Director
• Robert F Corvino,
  Director
• John P Iii Davidson,
  MD & Chief Corp Dev Officer
• David G Gomach,
  Managing Director & CFO
• John L Pietrzak,
  Director
• James J Mcnulty,
  President & CEO
• James E Newsome,
  Director
• Scott Robinson,
  MD, Corporate Development
• Bryan T Durkin,
  Director
• Michael G. Dennis,
  Director
• Patrick J Mulchrone,
  Director
• Rahael Seifu,
  Director
• Suzanne Sprague,
  Sr MD Global Head of Clearing
• Timothy Francis Mc Court,
  Sr MD Global Head Equity & FX
• Ken Vroman,
  Chief Transformation Officer
• Jonathan L Marcus,
  Sr MD General Counsel
• Kathryn Benesh,
  Director
• Harold Eugene Jr. Ford,
  Director
• Lynne Fitzpatrick,
  Sr MD Chief Financial Officer